Michael J. Mauro

机构：Memorial Sloan Kettering Cancer Center · ORCID：0000-0002-2251-4032

发表论文 470 篇 · 总被引 11090 次 · h-index 55

代表论文

• 2025 European LeukemiaNet recommendations for the management of chronic myeloid leukemia (2025 · Leukemia · 被引 110)
• Apoptosis-targeting BH3 mimetics: transforming treatment for patients with acute myeloid leukaemia (2025 · Nature Reviews Clinical Oncology · 被引 12)
• CARDINAL: A Phase 1 study of TERN-701, a novel investigational allosteric BCR::ABL1 inhibitor for patients with previously treated CML (2025 · Blood · 被引 5)
• Expert consensus definition of treatment intolerance in chronic myeloid leukemia in chronic phase (2025 · Hematology · 被引 4)
• Five-year molecular response and overall survival with first- and second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukemia in the chronic phase: a prospective, observational study – SIMPLICITY (2025 · Leukemia & lymphoma/Leukemia and lymphoma · 被引 4)
• How I treat advanced phases of CML (2025 · Blood · 被引 2)